Steward Partners Investment Advisory, LLC Seres Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $2,184 - $9,040	-400 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$18.46 - $24.36 $18,460 - $24,360	-1,000 Reduced 71.43%	400 $10,000
Q1 2021 May 14, 2021	BUY	$17.66 - $28.92 $17,660 - $28,920	1,000 Added 250.0%	1,400 $28,000
Q3 2020 Oct 30, 2020	BUY	$3.74 - $28.74 $1,496 - $11,496	400 New	400 $11,000
Q3 2018 Oct 23, 2018	SELL	$7.33 - $9.23 $2,932 - $3,692	-400 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$6.91 - $9.55 $2,764 - $3,820	400 New	400 $3,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $122M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.